Lates News

Hims & Hers Health fell 6.2% in early trading on Friday. The company has started offering a combination simvastatin tablet with a starting price of $49, putting pressure on Novo Nordisk and Eli Lilly. Novo Nordisk pledges to take legal action against the large-scale combination drug behavior.